Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Introduction: Administrative health records (AHRs) are used to conduct population-based post-market drug safety and comparative effectiveness studies to inform healthcare decision making. However, the cost of data extraction, and the challenges associated with privacy and securing approvals can make it challenging for researchers to conduct methodological research in a timely manner using real data. Generating synthetic AHRs that reasonably represent the real-world data are beneficial for developing analytic methods and training analysts to rapidly implement study protocols. We generated synthetic AHRs using two methods and compared these synthetic AHRs to real-world AHRs. We described the challenges associated with using synthetic AHRs for real-world study.

Methods: The real-world AHRs comprised prescription drug records for individuals with healthcare insurance coverage in the Population Research Data Repository (PRDR) from Manitoba, Canada for the 10-year period from 2008 to 2017. Synthetic data were generated using the Observational Medical Dataset Simulator II (OSIM2) and a modification (ModOSIM). Synthetic and real-world data were described using frequencies and percentages. Agreement of prescription drug use measures in PRDR, OSIM2 and ModOSIM was estimated with the concordance coefficient.

Results: The PRDR cohort included 169,586,633 drug records and 1,395 drug types for 1,604,734 individuals. Synthetic data for 1,000,000 individuals were generated using OSIM2 and ModOSIM. Sex and age group distributions were similar in the real-world and synthetic AHRs. However, there were significant differences in the number of drug records and number of unique drugs per person for OSIM2 and ModOSIM when compared with PRDR. For the average number of days of drug use, concordance with the PRDR was 16% (95% confidence interval [CI]: 12%-19%) for OSIM2 and 88% (95% CI: 87%-90%) for ModOSIM.

Conclusions: ModOSIM data were more similar to PRDR than OSIM2 data on many measures. Synthetic AHRs consistent with those found in real-world settings can be generated using ModOSIM. Synthetic data will benefit rapid implementation of methodological studies and data analyst training.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10898503PMC
http://dx.doi.org/10.23889/ijpds.v8i1.2176DOI Listing

Publication Analysis

Top Keywords

synthetic ahrs
24
synthetic data
16
data
12
drug records
12
osim2 modosim
12
synthetic
10
ahrs
9
generating synthetic
8
administrative health
8
health records
8

Similar Publications

Objectives: To explore real-world effectiveness of ixekizumab in Danish patients with axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA).

Methods: Observational cohort study based on data from the Danish nationwide quality registry, DANBIO. Patients with axSpA and PsA initiating ixekizumab (an interleukin 17 inhibitor (IL-17i)) between 2017 and 2024 were included.

View Article and Find Full Text PDF

Real-world effectiveness of recombinant zoster vaccine in self-identified Chinese individuals aged ≥50 years in the United States.

Hum Vaccin Immunother

December 2024

Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA.

We evaluated the vaccine effectiveness (VE) of two doses of recombinant zoster vaccine (RZV) against herpes zoster (HZ) and postherpetic neuralgia (PHN) in Chinese adults at Kaiser Permanente Southern California (KPSC). Chinese KPSC members were identified based on self-reported ethnicity or self-reported preferred spoken/written language. Those aged ≥50 years who received two doses of RZV 4 weeks to ≤ 6 months apart were matched 1:4 to RZV unvaccinated Chinese members and followed through June 2022; second doses were accrued 6/1/2018-12/31/2020.

View Article and Find Full Text PDF
Article Synopsis
  • Administrative health records (AHRs) are important for studying drug safety and effectiveness but are difficult to access and use due to costs and privacy issues.
  • Researchers generated synthetic AHRs using two methods (OSIM2 and ModOSIM) and compared them to real-world AHRs from Manitoba, highlighting challenges in creating useful synthetic data.
  • While ModOSIM data showed good agreement with real-world records, OSIM2 had significant discrepancies, indicating variability in the quality and usefulness of synthetic AHRs for research purposes.
View Article and Find Full Text PDF

Background: Some vaccines elicit nonspecific immune responses that may protect against heterologous infections. We evaluated the association between recombinant adjuvanted zoster vaccine (RZV) and coronavirus disease 2019 (COVID-19) outcomes at Kaiser Permanente Southern California.

Methods: In a cohort design, adults aged ≥50 years who received ≥1 RZV dose before 1 March 2020 were matched 1:2 to unvaccinated individuals and followed until 31 December 2020.

View Article and Find Full Text PDF
Article Synopsis
  • Aryl hydrocarbon receptor (AHR) is crucial for regulating skin barrier and immune responses, acting as a sensor for environmental interactions, especially during inflammation.
  • Various experimental methods, including in vitro tests and animal models, have explored AHR's involvement in skin conditions like psoriasis and atopic dermatitis, as well as the impact of AHR ligands like TCDD and FICZ.
  • Tapinarof, a new agent that modulates AHR, is being tested in clinical trials for its potential to reduce skin inflammation and improve barrier function in psoriatic and atopic dermatitis patients.
View Article and Find Full Text PDF